Log in

NYSEAMERICAN:NSPRInspireMD Stock Price, Forecast & News

$0.47
-0.01 (-2.08 %)
(As of 07/10/2020 04:00 PM ET)
Add
Compare
Today's Range
$0.46
Now: $0.47
$0.49
50-Day Range N/A
52-Week Range
$0.39
Now: $0.47
$5.30
Volume1.34 million shs
Average Volume2.00 million shs
Market Capitalization$2.04 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
InspireMD, Inc., a medical device company, focuses on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of coronary and vascular diseases. The company offers CGuard carotid embolic prevention systems for use in carotid artery applications; and MGuard prime embolic protection systems for use in patients with acute coronary syndromes, notably acute myocardial infarction, and saphenous vein graft coronary interventions. It is also developing NGuard, a neurovascular flow diverter that diverts blood flow away from cerebral aneurysms in order to seal the aneurysms. InspireMD, Inc. distributes its products in Europe, Latin America, the Middle East, and Asia. The company is headquartered in Tel Aviv, Israel.
Read More
InspireMD logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.5Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 3.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.82 out of 5 stars


Industry, Sector and Symbol

Stock Exchange NYSEAMERICAN
Industry Medical Appliances & Equipment
Sub-IndustryN/A
SectorMedical
Current SymbolNYSEAMERICAN:NSPR
Previous SymbolNASDAQ:NSPR
CUSIPN/A
Phone+1-857-4536553

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees43
Market Cap$2.04 million
Next Earnings Date8/4/2020 (Estimated)
OptionableNot Optionable

Receive NSPR News and Ratings via Email

Sign-up to receive the latest news and ratings for NSPR and its competitors with MarketBeat's FREE daily newsletter.

InspireMD (NYSEAMERICAN:NSPR) Frequently Asked Questions

Do Wall Street analysts recommend investors buy shares of InspireMD?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for InspireMD in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for InspireMD.

When is InspireMD's next earnings date?

InspireMD is scheduled to release its next quarterly earnings announcement on Tuesday, August 4th 2020. View our earnings forecast for InspireMD.

How were InspireMD's earnings last quarter?

InspireMD Inc (NYSEAMERICAN:NSPR) released its quarterly earnings data on Tuesday, May, 12th. The medical equipment provider reported ($0.43) EPS for the quarter, beating the Thomson Reuters' consensus estimate of ($0.63) by $0.20. The medical equipment provider earned $1.03 million during the quarter, compared to analyst estimates of $1 million. View InspireMD's earnings history.

When did InspireMD's stock split? How did InspireMD's stock split work?

Shares of InspireMD reverse split before market open on Monday, April 1st 2019. The 1-50 reverse split was announced on Tuesday, March 26th 2019. The number of shares owned by shareholders was adjusted after the market closes on Friday, March 29th 2019. An investor that had 100 shares of InspireMD stock prior to the reverse split would have 2 shares after the split.

What price target have analysts set for NSPR?

1 equities research analysts have issued 12-month price objectives for InspireMD's stock. Their forecasts range from $2.00 to $2.00. On average, they expect InspireMD's share price to reach $2.00 in the next twelve months. This suggests a possible upside of 325.5% from the stock's current price. View analysts' price targets for InspireMD.

Has InspireMD been receiving favorable news coverage?

Media coverage about NSPR stock has trended somewhat positive on Sunday, according to InfoTrie Sentiment Analysis. The research group rates the sentiment of press coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. InspireMD earned a news impact score of 1.3 on InfoTrie's scale. They also gave headlines about the medical equipment provider a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the stock's share price in the next few days. View the latest news about InspireMD.

Who are some of InspireMD's key competitors?

What other stocks do shareholders of InspireMD own?

Who are InspireMD's key executives?

InspireMD's management team includes the following people:
  • Dr. James J. Barry, Pres, CEO & Director (Age 60)
  • Mr. Craig Shore, CFO, Chief Admin. Officer, Sec. & Treasurer (Age 58)
  • Mr. Agustin V. Gago, Exec. VP & Chief Commercial Officer (Age 59)
  • Mr. Roei Samuri, VP of Operations
  • Dr. Sol J. Barer, Special Advisor to the Board (Age 72)

What is InspireMD's stock symbol?

InspireMD trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "NSPR."

How do I buy shares of InspireMD?

Shares of NSPR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is InspireMD's stock price today?

One share of NSPR stock can currently be purchased for approximately $0.47.

How big of a company is InspireMD?

InspireMD has a market capitalization of $2.04 million. InspireMD employs 43 workers across the globe.

What is InspireMD's official website?

The official website for InspireMD is www.inspiremd.com.

How can I contact InspireMD?

InspireMD's mailing address is 4 Menorat Hamaor St., TEL AVIV-YAFO, MA 6744832, Israel. The medical equipment provider can be reached via phone at +1-857-4536553.

This page was last updated on 7/12/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.